High-Dose and Sustained Delivery of HIV-1 Broadly Neutralizing Antibodies via Subcutaneous Injection of Hydrogel-based Microparticle Formations
Award Notice Posted
- Solicitation number
- PHS-2024-1
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Acousticabio, Inc.
- Set-aside
- Total Small Business
Opportunity facts
- Contract number
- 75N93024C00047 Federal contract award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Cambridge, Massachusetts 02139, United States
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice announces that the Department of Health and Human Services' National Institute of Allergy and Infectious Diseases has awarded a contract to ACOUSTICABIO, INC. for the development of high-dose and sustained delivery of HIV-1 broadly neutralizing antibodies via subcutaneous injection of hydrogel-based microparticle formations. The contract is valued at $295,116 and was awarded on August 1, 2024 under a total small business set-aside.
Notice text
Awarded contract 75N93024C00047 to ACOUSTICABIO, INC. for 295116.00 on 2024-08-01.
Notice history
6 of 9 notices listed here. See the rest on GovTribe.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity